Daré Bioscience, Inc. (DARE)
2.09
+0.10
(+5.03%)
USD |
NASDAQ |
Dec 11, 16:00
2.10
+0.01
(+0.48%)
After-Hours: 20:00
Daré Bioscience Cash from Investing (Quarterly): -0.1747M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Omeros Corp. | -6.861M |
| GeoVax Labs, Inc. | 0.00 |
| Vistagen Therapeutics, Inc. | -0.094M |
| Editas Medicine, Inc. | 39.57M |
| Spero Therapeutics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.4421M |
| Cash from Financing (Quarterly) | 18.65M |
| Free Cash Flow | -17.15M |
| Free Cash Flow Per Share (Quarterly) | -0.0484 |
| Free Cash Flow to Equity (Quarterly) | -0.6807M |
| Free Cash Flow to Firm (Quarterly) | -0.4036M |
| Free Cash Flow Yield | -84.34% |